Vyhláška Ministerstva zdravotnictví, kterou se mění vyhláška Ministerstva zdravotnictví č. 57/1997 Sb., kterou se stanoví léčivé přípravky plně hrazené z veřejného zdravotního pojištění a výše úhrad jednotlivých léčivých látek, ve znění pozdějších předpisů
| 224 | G04BX | jiná urologika, k léčbě benigní hyperplasie prostaty | p.o. | L/URN | |||
|---|---|---|---|---|---|---|---|
| 224.1 | G04CA01 | alfuzosin | p.o. | 7.5 | MG | 20,00 | L/URN |
| 224.2 | G04CA01 | alfuzosin (SR nebo retardované formy) | p.o. | 10 | MG | 20,00 | L/URN |
| 224.3 | G04CA02 | tamsulosin | p.o. | 0.4 | MG | 20,00 | L/URN |
| 224.4 | G04CA03 | terazosin | p.o. | 5 | MG | 16,80 | L/URN |
| 44311 | KORNAM 2MG | tbl 30x2mg | LEK | SLO | |||
| 44312 | KORNAM 5MG | tbl 30x5mg | LEK | SLO | |||
| 224.5 | G04CB01 | finasterid | p.o. | 5 | MG | 20,00 | L/URN |
| 224.6 | G04CX01 | extrakt Pyg. africanum | p.o. | 2 | DF | 16,00 | L/URN |
| 224.7 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 2 a víckrát denně) | p.o. | 2 | DF | 16,00 | L/URN |
| 57896 | SPALDA SABAL 160MG | cps 60x160mg | KKA | D | |||
| 57898 | SPALDA SABAL 160MG | cps 200x160mg | KKA | D | |||
| 57897 | SPALDA SABAL 160MG | cps 120x160mg | KKA | D | |||
| 224.8 | G04CX02 | extrakt Serenoa repens včetně kombinací (pevné lékové formy dávkované 1x denně) | p.o. | 1 | DF | 16,00 | L/URN |
| 59710 | PROSTAMOL UNO | cps 30x320mg | BCE | D | |||
| 57893 | SPALDA SABAL 320MG | cps 60x320mg | KKA | D | |||
| 224.9 | G04CX03 | mepartricin | p.o. | 150 | KU | 20,00 | L/URN |
| 225 | H01A | hormony předního laloku hypofýzy | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 225.1 | H01AA02 | tetrakosaktid (nedepotní lékové formy) | parent. | 0.25 | MG | 59,93 | L/END |
| 225.2 | H01AC01 | somatropin | parent. | 2 | U | 705,00 | L/J5 |
| 61227 | SAIZEN 10 | inj sic 1x10ut+5ml | SRO | CH | |||
| 226 | H01BA | vasopresin a jeho deriváty | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 226.1 | H01BA02 | desmopresin | parent. | 4 | RG | 82,41 | O |
| 226.2 | H01BA04 | terlipresin (do 0,5 mg včetně v jedné ampuli) | parent. | 1 | MG | 288,08 | H |
| 44356 | REMESTYP 0.5 | inj 5x5ml/0.5mg | FRL | CZ | |||
| 226.3 | H01BA04 | terlipresin (nad 0,5 mg v jedné ampuli) | parent. | 1 | MG | 245,27 | H |
| 226.4 | H01BA05 | omipresin | parent. | 5 | U | 27,57 | H |
| 227 | H01BA | vasopresin a jeho deriváty | lok. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 227.1 | H01BA02 | desmopresin (nosní kapky) | lok. | 25 | RG | 22,89 | |
| 02634 | ADIURETIN | gtt nas 1x5ml/0.5mg | FRL | CZ | |||
| 227.2 | H01BA02 | desmopresin (nosní spray) | lok. | 25 | RG | 22,89 | |
| 227.3 | H01BA02 | desmopresin (pevné lékové formy) | p.o. | 400 | RG | 22,89 | |
| 228 | H01BB | oxytocin a jeho deriváty | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 228.1 | H01BB02 | oxytocin (do 2 U v jedné ampuli včetně) | parent. | 15 | U | 49,20 | H |
| 00543 | OXYTOCIN FERRING-LECIVA | inj 5x2ml/2ut | FRL | CZ | |||
| 228.2 | H01BB02 | oxytocin (nad 2 U v jedné ampuli) | parent. | 15 | U | 21,96 | H |
| 00544 | OXYTOCIN FERRING-LECIVA | inj 5x1ml/5ut | FRL | CZ | |||
| 229 | H01CA | hormon uvolňující gonadotrofin | lok. | Z | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 229.1 | H01CA01 | gonadorelin (nasálně) | lok. | 1.2 | MG | 203,34 | Z |
| 229.2 | H01CA02 | nafarelin do 4 ml včetně v jednom balení (nasálně) | lok. | 0,4 | MG | 147,61 | Z |
| 45481 | SYNAREL | spr nas 1x4ml | SEA | POR | |||
| 229.3 | H01CA02 | nafarelin nad 4 ml v jednom balení (nasálně) | lok. | 0,4 | MG | 116,04 | Z |
| 83795 | SYNAREL | spr nas 1x8ml | SEA | POR | |||
| 229.4 | H01CC01 | ganirelix (antagonista gonadotropin releasing hormonu ) | parent. | 0,25 | MG | 1600,00 | Z |
| 05981 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | IRL | |||
| 05982 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | IRL | |||
| 05979 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 5x0.5ml | ORG | NL | |||
| 05980 | ORGALUTRAN 0.25MG/0.5ML INJ.ROZ | inj sol 1x0.5ml | ORG | NL | |||
| 229.5 | H01CC02 | cetrorelix s obsahem 0,25 mg v 1 ampuli | parent. | 0,25 MG | 1600,00 | Z | |
| 229.6 | H01CC02 | cetrorelix s obsahem 3 mg v 1 ampuli | parent. | 0,25 | MG | 667,00 | Z |
| 230 | H01CB | somatostatin a jeho deriváty | parent. | X | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 230.1 | H01CB01 | somatostatin | parent. | 6 | MG | 7754,00 | X |
| 66824 | SOMATOSTATIN | inj sic 1x3mg+solv. | UCB | B | |||
| 230.2 | H01CB02 | oktreotid | parent. | 1 | MG | 5016,00 | X |
| 93867 | SANDOSTATIN | inj 1x5ml/1mg-lahv. | SAN | CH | |||
| 93866 | SANDOSTATIN | inj 5x1 ml/0.5mg | SAN | CH | |||
| 230.3 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 10 mg | parent. | 0,35 7 | MG | 1378,40 | X |
| 230.4 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 20 mg | parent. | 0,71 4 | MG | 1840,57 | X |
| 230.5 | H01CB02 | oktreotid s podáváním 1x měsíčně s obsahem 30 mg | parent. | 1,07 2 | MG | 2297,30 | X |
| 230.6 H01CB03 | lantreotid | parent. | 2,14 | MG | 1789,03 | X | |
| 84701 | SOMATULINE P.R. | inj sic 1x30mg+solv | IPE | F | |||
| 231 | H02AA | mineralokortikoidy | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 231.1 | H02AA02 | fludrokortison | p.o. | 0.1 | MG | 4,76 | |
| 232 | H02AB | glukokortikoidy | p.o. | ||||
| 232.1 | H02AB01 | betamethason | p.o. | 1.5 | MG | 3,42 | |
| 232.2 | H02AB02 | dexamethason (4 mg v jedné tabletě a více) | p.o. | 1.5 | MG | 9,42 | |
| 83994 | FORTECORTIN 4 | tbl 20x4mg | MEC | D | |||
| 232.3 | H02AB02 | dexamethason (méně než 4 mg v jedné tabletě) | p.o. | 1.5 | MG | 3,42 | |
| 232.4 | H02AB04 | methylprednisolon (do 8 mg v jedné tabletě včetně) | p.o. | 7.5 | MG | 3,42 | |
| 232.5 | H02AB04 | methylprednisolon (nad 8 mg v jedné tabletě) | p.o. | 7.5 | MG | 5,43 | |
| 86606 | MEDROL 16MG | tbl 50x16mg(blistr) | PAU | B | |||
| 232.6 | H02AB07 | Prednison | p.o. | 10 | MG | 3,21 | |
| 00269 | PREDNISON 5 LECIVA | tbl 20x5mg | LEX | CZ | |||
| 02963 | PREDNISON 20 LECIVA | tbl 20x20mg(blistr) | LEX | CZ | |||
| 232.7 | H02AB08 | triamcinolon | p.o. | 7.5 | MG | 2,74 | |
| 232.8 | H02AB09 | hydrokortison | p.o. | 30 | MG | 7,33 | |
| 76205 | HYDROCORTISON 10MG JENAPHARM | tbl 20x10mg | VJP | D | |||
| 232.9 | H02AB10 | kortison | p.o. | 37.5 | MG | 5,72 | |
| 80588 | CORTISON CIBA 25MG | tbl 100x25mg | CGC | CH | |||
| 232.10 | H02AB07 | prednison (do 10 mg včetně) | p.rect. | 10 | MG | 17,30 | |
| 232.11 | H02AB07 | prednison (nad 30 mg) | p.rect. | 10 | MG | 4,59 | |
| 232.12 | H02AB07 | prednison (nad 10 do 30 mg včetně) | p.rect. | 10 | MG | 8,16 | |
| 233 | H02AB | glukokortikoidy | parent. | O | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 233.1 | H02AB | mazipredon | parent. | 30 | MG | 17,79 | O |
| 233.2 | H02AB01 | betamethason (depotní lékové formy) | parent. | 0.4 | MG | 3,69 | O |
| 89869 | DIPROPHOS | inj 5x1ml | SCH | B | |||
| 78257 | DIPROPHOS | inj 5x1ml | SCH | F | |||
| 233.3 | H02AB02 | dexamethason (do 8 mg v jedné ampuli včetně) | parent. | 1.5 | MG | 2,21 | O |
| 01673 | DEXAMED | inj 100x2ml/8mg | MOE | CY | |||
| 84090 | DEXAMED | inj 10x2ml/8mg | MOE | CY | |||
| 233.4 | H02AB02 | dexamethason (40 mg v jedné ampuli) | parent. | 1.5 | MG | 24,50 | O |
| 99479 | FORTECORTIN MONO 40(AMPULE) | inj 1x5ml/40mg | MEC | ||||
| 233.5 | H02AB04 | methylprednisolon (do 80 mg v jedné ampuli včetně) | parent. | 20 | MG | 35,70 | O |
| 233.6 | H02AB04 | methylprednisolon (nad 80 do 500 mg v jedné ampuli včetně) | parent. | 20 | MG | 22,11 | O |
| 233.7 | H02AB04 | methylprednisolon (nad 500 mg v jedné ampuli) | parent. | 20 | MG | 15,25 | O |
| 233.8 | H02AB06 | Prednisolon (do 50 mg v jedné ampuli včetně) | parent. | 10 | MG | 17,46 | O |
| 09705 | SOLU-DECORTIN H 50 | inj sic 1x50mg+1ml | MEC | D | |||
| 233.9 | H02AB06 | prednisolon (nad 50 mg v jedné ampuli) | parent. | 10 | MG | 12,51 | O |
| 09707 | SOLU-DECORTIN H 250 | inj sic 1x250mg+2ml | MEC | D | |||
| 233.10 | H02AB08 | triamcinolon | parent. | 7.5 | MG | 13,64 | O |
| 233.11 | H02AB09 | hydrokortison | parent. | 30 | MG | 11,19 | O |
| 06199 | SOLU-CORTEF | inj sic 25x100mg | PAU | B | |||
| 234 | H03AA | hormony štítné žlázy | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 234.1 | H03AA | hormony štítné žlázy | p.o. | 1 | DF | 2,15 | |
| 61160 | JODTHYROX | tbl 50 | MEC | D | |||
| 61161 | JODTHYROX | tbl 100 | MEC | D | |||
| 234.2 | H03AA01 | levothyroxin sodný (do 50 rg v 1 tabletě včetně) | p.o. | 0.15 | MG | 1,96 | |
| 69189 | EUTHYROX 50 | tbl 100x50rg | MEC | D | |||
| 47141 | LETROX 50 | tbl 100x50rg | BCE | D | |||
| 234.3 | H03AA01 | levothyroxin sodný (nad 50 rg do 100 rg včetně v 1 tabletě) | p.o. | 0.15 | MG | 1,37 | |
| 47144 | LETROX 100 | tbl 100x100rg | BCE | D | |||
| 97186 | EUTHYROX 100 | tbl 100x100rg | MEC | D | |||
| 234.4 | H03AA01 | levothyroxin sodný (nad 100 rg v 1 tabletě) | p.o. | 0.15 | MG | 1,12 | |
| 69191 | EUTHYROX 150 | tbl 100x150rg | MEC | D | |||
| 47133 | LETROX 150 | tbl 100x150rg | BCE | D | |||
| 234.5 | H03AA02 | liothyronin sodný | p.o. | 0.06 | MG | 4,40 | |
| 09805 | TERTROXIN | tbl 100x0.02mg | GLA | ZA | |||
| 234.6 | H03AA03 | kombinace levothyroxinu a liothyroninu | p.o. | 1 | DF | 1,81 | |
| 03875 | THYREOTOM | tbl 60x50rg | BCE | D | |||
| 234.7 | H03CA | jódová terapie | p.o. | 200 | RG | 1,81 | |
| 61158 | JODID 100 | tbl 100 | MEC | D | |||
| 61159 | JODID 200 | tbl 100 | MEC | D | |||
| 235 | H03B | thyreostatika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 235.1 | H03BA02 | propylthiouracil | p.o. | 0.1 | GM | 7,04 | |
| 09557 | PROPYCIL | tbl 100x50mg | SVP | D | |||
| 235.2 | H03BB01 | karbimazol | p.o. | 15 | MG | 3,11 | |
| 00066 | CARBIMAZOL SLOVAKOFARMA | tbl 100x5mg | SLO | SK | |||
| 235.3 | H03BB02 | thiamazol | p.o. | 10 | MG | 2,83 | |
| 235.4 | H03BC01 | perchlorát draselný | p.o. | 0.2 | GM | 1,66 | |
| 236 | H03B | thyreostatika | parent. | H | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 236.1 | H03BB02 | thiamazol | parent. | 10 | MG | 4,50 | H |
| 237 | H04AA | glukagon a jeho deriváty | parent. | L/DIA | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 237.1 | H04AA01 | glukagon | parent. | 1 | MG | 404,62 | L/DIA |
| 237.2 | H04AA01 | glukagon (ve formě hypokit) | parent. | 1 | MG | 811,39 | L/DIA |
| 83741 | GLUCAGEN 1MG HYPOKIT | inj sic 1mg+strik. | NOO | DK | |||
| 238 | H05BA | kalcitonin | inhal. | L/INT,GYN,ORT,END | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 238.1 | H05BA01 | kalcitonin (lososí, do 100 U včetně v jedné dávce) | inhal. | 200 | U | 104,13 | L/INT,ORT,END |
| 64662 | TONOCALCIN 100I.U.NOSNI SPREJ | spr nas 1x3.5ml | MCI | CZ | |||
| 30967 | OSTEODON 100 I.U. | sprnas1x3.5ml/28dÁv | LEX | CZ | |||
| 238.2 | H05BA01 | kalcitonin (lososí, nad 100 U v jedné dávce) | inhal. | 200 U | 83,00 | L/INT,ORT,END | |
| 10146 | TONOCALCIN 200 I.U.NOSNÍ SPREJ | spr nas 1x3.5ml | MCI | CZ | |||
| 239 | H05BA | kalcitonin | parent. | L/INT,GYN,ORT,END | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 239.1 | H05BA01 | kalcitonin (lososí) | parent. | 100 | U | 118,09 | L/INT,ORT, END |
| 239.2 | H05BA03 | kalcitonin (lidský, do 50 U v jedné ampuli včetně) | parent. | 100 | U | 125,37 | L/INT,ORT, END |
| 239.3 | H05BA03 | kalcitonin (lidský, nad 50 U v jedné ampuli) | parent. | 100 | U | 157,39 | L/INT,ORT, END |
| 240 | J01AA | tetracyklinová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 240.1 | J01AA02 | doxycyklin | p.o. | 0.1 | GM | 4,01 | |
| 12742 | DOXYHEXAL TABS | tbl 20x100mg | HEX | D | |||
| 12736 | DOXYHEXAL 200 TABS | tbl 20x200mg | HEX | D | |||
| 12735 | DOXYHEXAL 200 TABS | tbl 10x200mg | HEX | D | |||
| 12741 | DOXYHEXAL TABS | tbl 10x100mg | HEX | D | |||
| 97654 | DOXYBENE 100MG | cps 10x100mg | MCK | D | |||
| 240.2 | J01AA04 | lymecyklin | p.o. | 0.6 | GM | 4,01 | |
| 240.3 | J01AA06 | oxytetracyklin | p.o. | 1 | GM | 4,01 | |
| 240.4 | J01AA07 | tetracyklin | p.o. | 1 | GM | 4,01 | |
| 240.5 | J01AA08 | minocyklin | p.o. | 0.2 | GM | 4,01 | |
| 240.6 | J01AA52 | doxycyklin v kombinaci s ambroxolem | p.o. | 1 | DF | 6,26 | |
| 241 | J01AA | tetracyklinová antibiotika | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 241.1 | J01AA02 | doxycyklin | parent. | 0.1 | GM | 91,28 | K |
| 12705 | DOXYHEXAL SF | inj 2x5ml/100mg | HEX | D | |||
| 12706 | DOXYHEXAL SF | inj 5x5ml/100mg | HEX | D | |||
| 241.2 | J01AA09 | rolitetracyklin | parent. | 0.35 | GM | 94,63 | K |
| 242 | J01BA | amfenikolová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 242.1 | J01BA01 | chloramfenikol | p.o. | 3 | GM | 25,88 | |
| 71951 | CHLORAMPHENICOL LECIVA | cps 30x250mg | LEX | CZ | |||
| 243 | J01BA | amfenikolová antibiotika | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 243.1 | J01BA01 | chloramfenikol | parent. | 3 | GM | 267,93 | K |
| 97390 | CHLORAMPHENICOL SOLUBILE VUAB | inj sic 1x1gm | VUA | CZ | |||
| 243.2 | J01BA02 | thiamphenikol | parent. | 1.5 | GM | 176,31 | K |
| 244 | J01CA | aminopenicilinová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 244.1 | J01CA01 | ampicilin (pevné lékové formy) | p.o. | 2 | GM | 14,13 | |
| 244.2 | J01CA01 | ampicilin (tekuté lékové formy) | p.o. | 2 | GM | 17,20 | |
| 244.3 | J01CA04 | amoxicilin (pevné lékové formy) do 0,5 gm v 1 tabletě včetně | p.o. | 1 | GM | 10,12 | |
| 44338 | AMOXIHEXAL 500 | tbl obd 20x500mg | HHC | D | |||
| 53682 | AMOXICILLIN 500-SLOVAKOFARMA | cps 30x500mg | SLO | SK | |||
| 66364 | OSPAMOX 250MG | cps 12x250mg | BCA | A | |||
| 44337 | AMOXIHEXAL 500 | tbl obd 10x500mg | HHC | D | |||
| 66368 | OSPAMOX 500MG | tbl obd 12x500mg | BCA | A | |||
| 53681 | AMOXICILLIN 250-SLOVAKOFARMA | cps 30x250mg | SLO | SK | |||
| 66829 | AMOCLEN 500 | cps 30x500mg | LEX | CZ | |||
| 66828 | AMOCLEN 250 | cps 30x250mg | LEX | CZ | |||
| 32557 | OSPAMOX 500 MG | por tbl obd14x500mg | BCA | A | |||
| 244.4 | J01CA04 | amoxicilin (pevné lékové formy) nad 0,5 gm v 1tabletě | p.o. | 1 | GM | 9,06 | |
| 44339 | AMOXIHEXAL 750 | tbl obd 10x750mg | HHC | D | |||
| 44344 | AMOXIHEXAL 1000 | tbl obd 50x1000mg | HHC | D | |||
| 32558 | OSPAMOX 750 MG | por tbl obd14x750mg | BCA | A | |||
| 32559 | OSPAMOX 1000 MG | por tblobd 14x1000mg | BCA | A | |||
| 66369 | OSPAMOX 750MG | tbl obd 12x750mg | BCA | A | |||
| 44342 | AMOXIHEXAL 1000 | tbl obd 10x1000mg | HHC | D | |||
| 44341 | AMOXIHEXAL 750 | tbl obd 50x750mg | HHC | D | |||
| 65929 | AMOXICILLIN AL 1000 | tbl obd 10x1000mg | APA | D | |||
| 65958 | AMOXICILLIN AL 1000 | tbl obd 20x1000mg | APA | D | |||
| 66370 | OSPAMOX 1000MG | tbl obd 12x1000mg | BCA | A | |||
| 44343 | AMOXIHEXAL 1000 | tbl obd 20x1000mg | HHC | D | |||
| 244.5 | J01CA04 | amoxicilin (tekuté lékové formy do 0,5 gm včetně v 5 mililitrech) | p.o. | 1 | GM | 13,05 | |
| 84510 | AMOCLEN 250 | sir sic 1x5gm/100ml | LEX | CZ | |||
| 66366 | OSPAMOX 250MG/5ML | gra sus 1x60ml | BCA | A | |||
| 66367 | OSPAMOX 375MG/5ML | gra sus 1x60ml | BCA | A | |||
| 44345 | AMOXIHEXAL | plv sus 1x100ml | AAG | D | |||
| 44347 | AMOXIHEXAL FORTF | plv sus 1x100ml | AAG | D | |||
| 62050 | DUOMOX 500 | tbl 20x500mg | YEU | NL | |||
| 244.6 | J01CA04 | amoxicilin (tekuté lékové formy nad 0,5 gm v 5 mililitrech) | p.o. | 1 | GM | 10,00 | |
| 44334 | AMOXIHEXAL 750 TABS | tbl sol 24x750mg | HHC | D | |||
| 44336 | AMOXIHEXAL 1000 TABS | tbl sol 24x1000mg | HHC | D | |||
| 44333 | AMOXIHEXAL 750 TABS | tbl sol 12x750mg | HHC | D | |||
| 44335 | AMOXIHEXAL 1000 TABS | tbl sol 12x1000mg | HHC | D | |||
| 244.7 | J01CA06 | bakampicilin | p.o. | 1.2 | GM | 16,62 | |
| 245 | J01CA | aminopenicilinová antibiotika | parent. | K | |||
| 245.1 | J01CA01 | ampicilin | parent. | 2 | GM | 27,08 | K |
| 246 | J01CA | acylureidová antibiotika | parent. | U/ATB | |||
| 246.1 | J01CA09 | azlocilin | parent. | 12 | GM | 637,48 | U/ATB |
| 246.2 | J01CA12 | piperacilin | parent. | 14 | GM | 1297,98 | U/ATB |
| 246.3 | J01CA13 | tikarcilin | parent. | 15 | GM | 1980,92 | U/ATB |
| 247 | J01CE | na beta-laktamázu citlivé peniciliny | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 247.1 | J01CE02 | fenoxymethylpenicilin (méně než 500 KU v jedné tabletě) | p.o. | 2 | GM | 21,02 | |
| 92805 | V-PENICILIN 250MG SLOVAKOFARMA | tbl 30x250mg-blistr | SLO | SK | |||
| 92434 | V-PENICILIN 0.4MEGA BIOTIKA | tbl 30x400ku | BTA | SK | |||
| 247.2 | J01CE02 | fenoxymethylpenicilin ( od 500 KU včetně do 900 KU včetně v jedné tabletě) | p.o. | 2 | GM | 19,11 | |
| 45996 | OSPEN 500 | tbl obd 30x500ku | BCA | A | |||
| 56831 | OSPEN 500 | tbl obd 12x500ku | BCA | A | |||
| 92435 | V-PENICILIN 0.8MEGA BIOTIKA | tbl 30x800ku | BTA | SK | |||
| 92806 | V-PENICILIN 500MG SLOVAKOFARMA | tbl 30x500mg-blistr | SLO | SK | |||
| 247.3 | J01CE02 | fenoxymethylpenicilin (nad 900 KU v jedné tabletě) | p.o. | 2 | GM | 19,65 | |
| 05960 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 20x750mg-blistr | SLO | SK | |||
| 92436 | V-PENICILIN 1.2MEGA BIOTIKA | tbl 30x1.2mu | BTA | SK | |||
| 66359 | OSPEN 1000 | tbl obd 12x1000ku | BCA | A | |||
| 30069 | PENCID 1000 | tbl obd 30x1mu | LEX | CZ | |||
| 66360 | OSPEN 1500 | tbl obd 12x1500ku | BCA | A | |||
| 49513 | PENBENE | tbl obd 30x1mu | MCK | D | |||
| 01881 | PENBENE 1 000 000 | tbl obd 21x1mu | MCK | D | |||
| 65356 | PENBENE | tbl obd 12x1mu | MCK | D | |||
| 57778 | PENBENE 1500000 | tbl obd 21 | MCK | D | |||
| 64937 | PENCID 1000 | tbl obd 20x1mu | LEX | CZ | |||
| 64936 | PENCID 1500 | tbl obd 20x1.5mu | LEX | CZ | |||
| 45998 | OSPEN 1500 | tbl obd 30x1500ku | BCA | A | |||
| 44708 | V-PENICILIN 750MG SLOVAKOFARMA | tbl 30x750mg-blistr | SLO | SK | |||
| 45997 | OSPEN 1000 | tbl obd 30x1000ku | BCA | A | |||
| 247.4 | J01CE06 | penamecilin | p.o. | 1.05 | GM | 15,05 | |
| 56442 | PENCLEN | tbl 30x350mg-blistr | SLO | SK | |||
| 247.5 | J01CE10 | benzathin fenoxymethyl-penicilin | p.o. | 2 | GM | 29,43 | |
| 76213 | OSPEN 750 | sir 60ml 750mg/5ml | KRK | SLO | |||
| 49549 | OSPEN 400MG | sir 1x150ml | BCA | A | |||
| 247.6 | J01CE02 | fenoxymethyl-penicilin (tekuté lékové formy do 250 KU v 5 ml včetně) | p.o. | 2 | GM | 69.99 | |
| 247.7 | J01CE02 | fenoxymethyl-penicilin (tekuté lékové formy nad 250 KU v 5 ml) | p.o. | 2 | GM | 26,30 | |
| 248 | J01CE | na beta-laktamázu citlivé peniciliny | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 248.1 | J01CE01 | benzylpenicilin (do 1 MU v jedné ampuli včetně) | parent. | 3.6 | GM | 123,86 | K |
| 01093 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x1mu | BTA | SK | |||
| 02136 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x500ku | BTA | SK | |||
| 248.2 | J01CE01 | benzylpenicilin (nad 1 MU v jedné ampuli) | parent. | 3.6 | GM | 49,32 | K |
| 93405 | PENICILIN G DRASEL.SOL BIOTIKA | inj sic 10x5mu | BTA | SK | |||
| 248.3 | J01CE08 | benzathin benzylpenicilin (do 0,6 MU v jedné ampuli včetně) | parent. | 2 | MU | 70,63 | K |
| 248.4 | J01CE08 | benzathin benzylpenicilin (nad 0,6 MU v jedné ampuli) | parent. | 2 | MU | 27,83 | K |
| 01764 | RATARPEN 2.4 M.U.I. | inj sic 50x2,4mu | BCA | A | |||
| 248.5 | J01CE09 | prokain penicilin (do 0,6 MU v jedné dávce včetně) | parent. | 2 | MU | 79,58 | K |
| 248.6 | J01CE09 | prokain penicilin (nad 0,6 MU v jedné dávce) | parent. | 2 | MU | 39,05 | K |
| 01102 | PROKAIN PENICILIN G BIOTIKA | inj 10x1.5mu | BTA | SK | |||
| 248.7 | J01CE30 | kombinace | parent. | 0.5 | DF | 10,36 | K |
| 02723 | PENDEPON COMPOSITUM | inj 10x1.5mu | BTA | SK | |||
| 249 | J01CF | vůči beta-laktamáze stabilní peniciliny | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 249.1 | J01CF02 | cloxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 249.2 | J01CF02 | cloxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 249.3 | J01CF04 | oxacilin (pevné lékové formy) | p.o. | 2 | GM | 28,74 | |
| 76201 | PROSTAPHLIN 500MG | cps 40x500mg | BMS | I | |||
| 249.4 | J01CF04 | oxacilin (tekuté lékové formy) | p.o. | 2 | GM | 39,98 | |
| 250 | J01CF | vůči beta-laktamáze stabilní peniciliny | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 250.1 | J01CF04 | oxacilin | parent. | 2 | GM | 95,80 | K |
| 92359 | PROSTAPHLIN 1000MG | inj sic 1x1000mg | BMS | I | |||
| 251 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 251.1 | J01CR04 sultamicilin (pevné lékové formy) | p.o. | 1.5 | GM | 83,58 | ||
| 251.2 | J01CR04 | sultamicilin (tekuté lékové formy) | p.o. | 1.5 | GM | 80,90 | |
| 251.3 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, do 375 mg v 1 tabletě včetně) | p.o. | 1 | GM | 31,80 | |
| 46093 | ENHANCIN 250/125MG | tbl obd 21x250mg | RXY | IND | |||
| 97657 | AUGMENTIN 375MG | tbl obd 21x375mg | LEX | CZ | |||
| 85524 | AMOKSIKLAV | tbl obd 21x375mg | LEK | SLO | |||
| 251.4 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 375 mg do 625 mg včetně v 1 tabletě) | p.o. | 1 | GM | 28,98 | |
| 83738 | AUGMENTIN 625MG | tbl obd 21x625mg | LEX | CZ | |||
| 46094 | ENHANCIN 500/125MG | tbl obd 21x500mg | RXY | IND | |||
| 85525 | AMOKSIKLAV | tbl obd 21x625mg | LEK | SLO | |||
| 53577 | CURAM 625MG | tbl obd 21x625mg | BCA | A | |||
| 251.5 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (pevné lékové formy, nad 625 mg v 1 tabletě) | p.o. | 1 | GM | 27,18 | |
| 53959 | AUGMENTIN 1GM | tbl obd 14x1gm | LEX | CZ | |||
| 12494 | AUGMENTIN 1GM | tbl 14x1gm | SKB | GB | |||
| 05951 | AMOKSIKLAV 1G | tbl obd 14x1gm | LEA | SLO | |||
| 251.6 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy do 156 mg v 5 ml včetně) | p.o. | 1 | GM | 47,44 | |
| 97658 | AUGMENTIN 156MG/5ML | sir sic 1x100ml | LEX | CZ | |||
| 53567 | CURAM 156.25MG/5ML | plv sus 1x100ml | BCA | A | |||
| 251.7 | J01CR02 | amoxicilin a inhibitor beta-laktamázy (tekuté lékové formy, nad 156 mg v 5 ml) | p.o. | 1 | GM | 31,12 | |
| 83739 | AUGMENTIN 312MG/5ML | sir sic 1x100ml | LEX | CZ | |||
| 53571 | CURAM 312.5MG/5ML | plv sus 1x100ml | BCA | A | |||
| 252 | J01CR | kombinace inhibitoru beta-laktamázy s peniciliny, nebo kombinace penicilinů | parent. | U/ATB | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 252.1 | J01CR01 | ampicilin a enzymový inhibitor | parent. | 2 | GM | 162,17 | U/ATB |
| 252.2 | J01CR02 | amoxicilin a inhibitor beta-laktamázy | parent. | 1 | GM | 109,88 | U/ATB |
| 32279 | AMOKSIKLAV 600 MG | inj sic 5x600mg | LEA | SLO | |||
| 97660 | AUGMENTIN 1.2GM | inj sic 5x1.2gm | LEX | CZ | |||
| 72972 | AMOKSIKLAV 1.2GM | inj sic 5x1.2gm | LEK | SLO | |||
| 72973 | AMOKSIKLAV 600MG | inj sic 5x600mg | LEK | SLO | |||
| 32280 | AMOKSIKLAV 1.2 G | inj sic 5x1.2gm | LEA | SLO | |||
| 252.3 | J01CR03 | tikarcilin a inhibitor beta-laktamázy | parent. | 15 | GM | 1820,84 | U/ATB |
| 252.4 | J01CR05 | piperacilin a inhibitor beta-laktamázy | parent. | 14 | GM | 1980,92 | U/ATB |
| 252.5 | J01CR50 | kombinace penicilinů | parent. | 3 | DF | 71,80 | U |
| 252.6 | J01DA | cefoperazon a inhibitor beta-laktamázy | parent. | 2 | GM | 397,00 | U/ATB |
| 253 | J01DA | cefalosporinová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 253.1 | J01DA01 | cefalexin (pevné lékové formy) | p.o. | 2 | GM | 38,13 | |
| 66356 | OSPEXIN 500MG | tbl obd 12x500mg | BCA | A | |||
| 66357 | OSPEXIN 1000MG | tbl obd 12x1000mg | BCA | A | |||
| 06158 | ORACEF | cps 16x500mg | KRK | SLO | |||
| 55779 | CEFACLEN 250 | cps 30x250mg | SLO | SK | |||
| 55782 | CEFACLEN 500 | cps 30x500mg | SLO | SK | |||
| 253.2 | J01DA01 | cefalexin (tekuté lékové formy) | p.o. | 2 | GM | 44,33 | |
| 66354 | OSPEXIN 250MG/5ML | gra sus 1x60ml | BCA | A | |||
| 66355 | OSPEXIN 375MG/5ML | gra sus 1x60ml | BCA | A | |||
| 253.3 | J01DA06 | cefuroxim axetil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 253.4 | J01DA06 | cefuroxim axetil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 253.5 | J01DA08 | cefaklor (pevné lékové formy do 375 mg v 1 tabletě včetně) | p.o. | 1.5 | GM | 71,43 | |
| 53153 | VERCEF 250MG | cps 7x3(blistr) | RXY | IND | |||
| 58765 | SERVICLOR 250 MG | cps 21x250mg | BCA | A | |||
| 47210 | VERCEF MR 375 MG | por tblret 14x375mg | RXY | IND | |||
| 01665 | CEFACLOR 250-SL | cps 21x250mg | SLO | SK | |||
| 253.6 | J01DA08 | cefaklor (pevné lékové formy nad 375 mg v 1 tabletě) | p.o. | 1.5 | GM | 66,03 | |
| 32156 | SERVICLOR 500 MG | cps 21x500mg | BCA | A | |||
| 45194 | CEC 500 | tbl obd 20x500mg | SFS | D | |||
| 01667 | CEFACLOR 500-SL | cps 21x500mg | SLO | SK | |||
| 45193 | CEC 500 | tbl obd 10x500mg | SFS | D | |||
| 53157 | VERCEF 500MG | cps 7x3(blistr) | RXY | IND | |||
| 253.7 | J01DA08 | cefaklor (tekuté lékové formy, do 125 mg/5 ml včetně) | p.o. | 1.5 | GM | 103,11 | |
| 58763 | SERVICLOR 125 MG/5ML | por gra sus 1x100ml | BCA | A | |||
| 253.8 | J01DA08 | cefaklor (tekuté lékové formy, nad 125 mg/5 ml) | p.o. | 1.5 | GM | 86,27 | |
| 53152 | VERCEF 250MG/5ML | plv sus 1x100ml | RXY | IND | |||
| 58764 | SERVICLOR 250 MG/5ML | por gra sus 1x100ml | BCA | A | |||
| 66282 | CEFACLOR AL SUSP. | gra sus 1x100ml/5gm | APA | D | |||
| 253.9 | J01DA09 | cefadroxil (pevné lékové formy) | p.o. | 2 | GM | 40,00 | |
| 44802 | BIODROXIL | tbl obd 12x1000mg | BCA | A | |||
| 44799 | BIODROXIL | cps 12x500mg | BCA | A | |||
| 253.10 | J01DA09 | cefadroxil (tekuté lékové formy) | p.o. | 2 | GM | 63,30 | |
| 253.11 | J01DA23 | cefixim | p.o. | 0.4 | GM | 107,35 | ATB |
| 253.12 | J01DA26 | cefetamet | p.o. | 1 | GM | 107,53 | ATB |
| 253.13 | J01DA33 | cefpodoxim | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.14 | J01DA39 | ceftibuten | p.o. | 0.4 | GM | 92,35 | ATB |
| 253.15 | J01DA41 | cefprozil (pevné lékové formy) | p.o. | 1 | GM | 92,35 | |
| 253.16 | J01DA41 | cefprozil (tekuté lékové formy) | p.o. | 1 | GM | 141,75 | |
| 254 | J01DA | cefalosporinová antibiotika | parent. | U/ATB P | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu ceftriaxonem v ambulantní péči ordinuje neurolog, infekcionista, dermatolog, pediatr nebo revmatolog:
- a) inciální léčba bakteriální meningitidy u dětí mladších 18 let,
- b) léčba Lymské boreliózy II. a III. stádium (doložené laboratorním vyšetřením),
- c) léčba nekomplikované akutní kapavky (jednorázová nitrosvalová aplikace 250 mg ceftriaxonu).
| 254.1 | J01DA03 | cefalotin | parent. | 4 | GM | 188,18 | U/ATB |
|---|---|---|---|---|---|---|---|
| 85512 | CEFALOTIN BIOTIKA | inj sic 50x1gm | BTA | SK | |||
| 254.2 | J01DA04 | cefazolin | parent. | 3 | GM | 149,40 | U/ATB |
| 02205 | CEFAZOLINE PANPHARMA | inj sic 25x1gm | LPA | F | |||
| 85510 | VULMIZOLIN 1.0 | inj sic 50x1gm | BTA | SK | |||
| 91148 | VULMIZOLIN 1.0 | inj sic 10x1gm | BTA | SK | |||
| 84018 | CEFAZOLINE PANPHARMA | inj sic 50x1gm | LPA | F | |||
| 83111 | ORIZOLIN 1000 | inj sic 1x1000mg | CAI | IND | |||
| 254.3 | J01DA05 | cefoxitin | parent. | 6 | GM | 937,79 | U/ATB |
| 254.4 | J01DA06 | cefuroxim | parent. | 4 | GM | 439,20 | U/ATB |
| 64835 | AXETINE 750MG | inj sic 10x750mg | MOE | CY | |||
| 64832 | AXETINE 1.5GM | inj sic 50x1.5gm | MOE | CY | |||
| 64833 | AXETINE 1.5GM | inj sic 100x1.5gm | MOE | CY | |||
| 64831 | AXETINE 1.5GM | inj sic 10x1.5gm | MOE | CY | |||
| 64830 | AXETINE 1.5GM | inj sic 1x1.5gm | MOE | CY | |||
| 64837 | AXETINE 750MG | inj sic 100x750mg | MOE | CY | |||
| 254.5 | J01DA07 | cefamandol | parent. | 6 | GM | 615,68 | U/ATB |
| 254.6 | J01DA10 | cefotaxim do 1 g včetně v jedné ampuli | parent. | 6 | GM | 524,01 | U/ATB |
| 05770 | TAXCEF | inj sic 1x1gm | RXY | IND | |||
| 94176 | CEFOTAXIME | inj 1x1gm | LEK | SLO | |||
| 254.7 | J01DA10 | cefotaxim nad 1 g v jedné ampuli | parent. | 6 | GM | 459,00 | U/ATB |
| 05748 | TAXCEF 2G | inj sic 1x2gm | RXY | IND | |||
| 254.8 | J01DA11 | ceftazidim do 500 mg včetně v jedné ampuli | parent. | 6 | GM | 1736,18 | U/ATB |
| 254.9 | J01DA11 | ceftazidim nad 500 mg v jedné ampuli | parent. | 6 | GM | 1739,99 | U/ATB |
| 254.10 | J01DA12 | cefsulodin | parent. | 6 | GM | 615,68 | U/ATB |
| 254.11 | J01DA13 | ceftriaxon | parent. | 2 | GM | 555,00 | ambulantně: K/P ústavně: U/ATB |
| 64638 | OFRAMAX 1 G | inj sic 1x1gm | RXY | IND | |||
| 80662 | LENDACIN 1GM | inj sic 5x1gm | LEK | SLO | |||
| 254.12 | J01DA22 | ceftizoxim | parent. | 4 | GM | 615,68 | U/ATB |
| 254.13 | J01DA24 | cefepim | parent. | 4 | GM | 1605,91 | U/ATB |
| 254.14 | J01DA30 | cefapirin | parent. | 4 | GM | 194,73 | U/ATB |
| 254.15 | J01DA32 | cefoperazon | parent. | 6 | GM | 1526,24 | U/ATB |
| 254.16 | J01DA37 | cefpirom | parent. | 4 | GM | 1638,40 | U/ATB |
| 86598 | CEFROM 2GM | inj sic 1x2gm | ROU | F | |||
| 255 | J01DF | monobaktámová antibiotika | parent. | U/ATB | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 255.1 | J01DF01 | aztreonam | parent. | 4 | GM | 1645,60 | U/ATB |
| 86412 | AZACTAM | inj sic 1x1gm | BMS | I | |||
| 256 | J01DH | karbapenemová antibiotika | parent. | U/ATB | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 256.1 | J01DH02 | meropenem | parent. | 2 | GM | 2194,52 | U/ATB |
| 83487 | MERONEM 500MG I.V. | inj sic 10x500mg | ZNC | GB | |||
| 256.2 | J01DH51 | imipenem a inhibitor enzymu | parent. | 2 | GM | 2238,99 | U/ATB |
| 12091 | TIENAM I.M. | inj sic 1x500/500mg | MSD | CH | |||
| 257 | J01EB | krátkodobě působící sulfonamidy | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 257.1 | J01EA01 | trimethoprim (do 100 mg v jedné tabletě včetně) | p.o. | 0.4 GM | 11,88 | ||
| 89813 | TRIPRIM 100MG | tbl 20x100mg | MCK | D | |||
| 89812 | TRIPRIM 100MG | tbl 10x100mg | MCK | D | |||
| 257.2 | J01EA01 | trimethoprim (nad 100 mg v jedné tabletě) | p.o. | 0.4 | GM | 8,94 | |
| 89816 | TRIPRIM 200MG | tbl 20x200mg | MCK | D | |||
| 89815 | TRIPRIM 200MG | tbl 10x200mg | MCK | D | |||
| 257.3 | J01EB05 | sulfafurazol | p.o. | 4 | GM | 13,64 | |
| 258 | J01EE | sulfonamidy kombinované s trimetoprimem | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 258.1 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy, do 120 mg v jedné tabletě včetně) | p.o. | 1.92 | GM | 17,06 | |
| 258.2 | J01EE01 | sulfamethoxazol a trimethoprim (pevné lékové formy nad 120 mg v jedné tabletě) | p.o. | 1.92 | GM | 6,84 | |
| 75023 | COTRIMOXAZOL AL FORTE | tbl 20x960mg | APA | D | |||
| 75022 | COTRIMOXAZOL AL FORTE | tbl 10x960mg | APA | D | |||
| 87758 | ORIPRIM | tbl 100x480mg | CAI | IND | |||
| 12917 | BISMORAL 480 | tbl 20x480mg | SLO | SK | |||
| 97868 | ORIPRIM | tbl 20x480mg | CAI | IND | |||
| 258.3 | J01EE01 | sulfamethoxazol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 22,39 | |
| 258.4 | J01EE03 | sulfametrol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 258.5 | J01EE03 | sulfametrol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | |
| 258.6 | J01EE04 | sulfamonoxol a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 258.7 | J01EE04 | sulfamonoxol a trimethoprim (tekuté lékové formy) | p.o. | 1.92 | GM | 23,07 | |
| 258.8 | J01EE05 | sulfadimidin a trimethoprim (pevné lékové formy) | p.o. | 1.92 | GM | 6,94 | |
| 259 | J01EE | sulfonamidy kombinované s trimetoprimem | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 259.1 | J01EE01 | sulfamethoxazol a trimethoprim | parent. | 1.92 | GM | 127,04 | K |
| 91281 | PRIMOTREN I.V. | inj 10x5ml | LEK | SLO | |||
| 260 | J01FA | makrolidová antibiotika | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 260.1 | J01FA | telithromycin | p.o. | 800 | MG | 96,80 | U/ATB |
| 260.2 | J01FA01 | erythromycin (pevné lékové formy) | p.o. | 1 | GM | 20,09 | |
| 260.3 | J01FA01 | erythromycin (tekuté lékové formy) | p.o. | 1 | GM | 45,61 | |
| 97508 | ERYTHROMYCIN-RATIO.TS 200MG/5ML | plv sus 1x100ml | MCK | D | |||
| 55584 | MEROMYCIN 200MG/5ML | plv sus 1x60ml | MCK | D | |||
| 55585 | MEROMYCIN 200MG/5ML | plv sus 1x100ml | MCK | D | |||
| 260.4 | J01FA02 | spiramycin | p.o. | 3 | GM | 48,42 | |
| 260.5 | J01FA05 | oleandomycin | p.o. | 1 | GM | 15,36 | |
| 260.6 | J01FA06 | roxithromycin (do 100 mg v jedné tabletě včetně) | p.o. | 0.3 | GM | 43,77 | |
| 260.7 | J01FA06 | roxithromycin (nad 100 mg v jedné tabletě) | p.o. | 0.3 | GM | 37,84 | |
| 260.8 | J01FA07 | josamycin (pevné lékové formy) | p.o. | 2 | GM | 34,05 | |
| 260.9 | J01FA07 | josamycin (tekuté lékové formy) | p.o. | 1 | GM | 42,58 | |
| 260.10 | J01FA09 | klarithromycin (pevné lékové formy) | p.o. | 0.5 | GM | 48,40 | |
| 53282 | FROMILID 250 | tbl obd 14x250mg | KRK | SLO | |||
| 53283 | FROMILID 500 | tbl obd 14x500mg | KRK | SLO | |||
| 260.11 | J01FA09 | klarithromycin (tekuté lékové formy) | p.o. | 0.5 | GM | 70,00 | |
| 260.12 | J01FA10 | azithromycin (pevné lékové formy do 125 mg v 1 tabletě nebo tobolce včetně) | p.o. | 0.25 | GM | 63,77 | |
| 260.13 | J01FA10 | azithromycin (pevné lékové formy nad 125 mg v 1 tabletě nebo tobolce) | p.o. | 0.25 | GM | 63,27 | |
| 260.14 | J01FA10 | azithromycin (tekuté lékové formy) | p.o. | 0.25 | GM | 86,60 | |
| 260.15 | J01FA13 | dirythromycin | p.o. | 0.5 | GM | 48,42 | |
| 260.16 | J01RA | kombinace antibakteriálních léčiv (spiramycin/ metronidazol) | p.o. | 5 | DF | 32,16 | |
| 261 | J01FA | makrolidová antibiotika | parent. | K | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 261.1 | J01FA01 | erythromycin | parent. | 1 | GM | 717,50 | K |
| 261.2 | J01FA02 | spiramycin | parent. | 4,5 | MU | 663,67 | K |
| 78174 | ROVAMYCINE 1.5 M.I.U. | plv inf 1x1.5mu | RSL | F | |||
| 261.3 | J01FA09 | klaritromycin | parent. | 1 | GM | 861,00 | K |
| 262 | J01FF | linkosamidová antibiotika | p.o. | ATB | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 262.1 | J01FF01 | klindamycin (pevné lékové formy) | p.o. | 1.2 | GM | 55,46 | |
| 56867 | KLIMICIN 300MG | cps 16x300mg | LEK | SLO | |||
| 03365 | DALACIN C | cps 16x150mg | UPJ | B | |||
| 94574 | KLIMICIN | cps 16x150mg | LEK | SLO | |||
| 83458 | DALACIN C | cps 16x300mg | UPJ | B | |||
| 262.2 | J01FF01 | klindamycin (tekuté lékové formy) | p.o. | 1.2 | GM | 136,53 | |
| 262.3 | J01FF02 | linkomycin (pevné lékové formy) | p.o. | 1.8 | GM | 29,08 | ATB |
| 91997 | NELOREN | cps 16x500mg | LEK | SLO | |||
| 262.4 | J01FF02 | linkomycin (tekuté lékové formy) | p.o. | 1.8 | GM | 160,62 | ATB |
| 263 | J01FF | linkosamidová antibiotika | parent. | U/ATB | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 263.1 | J01FF01 | klindamycin (do 0,3 gm včetně v jedné ampuli) | parent. | 1.8 | GM | 598,67 | U/ATB |
| 263.2 | J01FF01 | klindamycin (nad 0,3 gm v jedné ampuli) | parent. | 1.8 | GM | 548,92 | U/ATB |
| 263.3 | J01FF02 | linkomycin | parent. | 1.8 | GM | 49,17 | U/ATB |
| 263.4 | J01FG02 | quinupristin v kombinaci s dalfopristinem | parent | 1 | DF | 2492,00 | U/ATB |
| 264 | J01GA | streptomycin a jeho deriváty | parent. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 264.1 | J01GA01 | streptomycin | parent. | 1 | GM | 117,10 | |
| 59732 | STREPTOMYCIN GRUNENTHAL 1.0 G | inj sic 1x1gm+solv. | GRU | D | |||
| 265 | J01GB | aminoglykosidová antibiotika | parent. | U/ATB | |||
| --- | --- | --- | --- | --- | --- | --- | --- |
| 265.1 | J01GB01 | tobramycin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 43,84 | U/ATB |
| 265.2 | J01GB01 | tobramycin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,02 | U/ATB |
| 265.3 | J01GB03 | gentamicin (do 40 mg v jedné ampuli včetně) | parent. | 0.24 | GM | 45,18 | U/ATB |
| 265.4 | J01GB03 | gentamicin (nad 40 mg v jedné ampuli) | parent. | 0.24 | GM | 23,61 | U/ATB |
| 265.5 | J01GB03 | gentamicin (lékové formy pěny) | lok. | 130 | MG | 2411,98 | U/ATB |
| 265.6 | J01GB03 | gentamicin (lékové formy kuliček k impiantaci) | imp. | 1 | DF | 152,06 | U/ATB |
| 265.7 | J01GB05 | neomycin | parent. | 1 | GM | 122,34 | U/ATB |
| 265.8 | J01GB06 | amikacin (do 100 mg v jedné ampuli včetně) | parent. | 1 | GM | 741,01 | U/ATB |
| 265.9 | J01GB06 | amikacin (nad 100 mg v jedné ampuli) | parent. | 1 | GM | 398,66 | U/ATB |
| 265.10 | J01GB07 | netilmicin (do 50 mg v jedné ampuli včetně) | parent. | 0.35 | GM | 519,93 | U/ATB |
| 265.11 | J01GB07 | netilmicin (nad 50 mg v jedné ampuli) | parent. | 0.35 | GM | 304,57 | U/ATB |
| 265.12 | J01GB11 | isepamicin (do 250 mg včetně v jedné ampuli) | parent. | 1 | GM | 620,27 | U/ATB |
| 265.13 | J01GB11 | isepamicin (nad 250 mg v jedné ampuli) | parent. | 1 | GM | 516,90 | U/ATB |
| 266 | J01MA | fluorované chinolony | p.o. | ||||
| --- | --- | --- | --- | --- | --- | --- | --- |
K léčbě sparfloxacinem a trovafloxacinem je třeba konzultace a schválení antibiotického střediska.
| 266.1 | J01MA01 | ofloxacin | p.o. | 0.4 | GM | 24,50 | | | 12349 | ZANOCIN 200MG | tbl obd 10x200mg | RXY | IND | | | | | 266.2 | J01MA02 | Ciprofloxacin | p.o. | 1 | GM | 24,50 | | | 87104 | CIFLOXINAL | tbl obd 10x250mg | PMP | CZ | | | | | 44985 | CIPLOX 500 | tbl obd 10x500mg | CIA | IND | | | | | 53715 | CIFLOXINAL | tbl obd 200x250mg | PMP | CZ | | | | | 87105 | CIFLOXINAL | tbl obd 20x250mg | PMP | CZ | | | | | 53201 | CIPHIN 250 | tbl obd 10x250mg | SLO | SK | | | | | 44986 | CIPLOX 500 | tbl obd 50x500mg CIA | IND | | | | | | 44988 | CIPLOX 250 | tbl obd 10x250mg | CIA | IND | | | | | 44989 | CIPLOX 250 | tbl obd 50x250mg | CIA | IND | | | | | 53202 | CIPHIN 500 | tbl obd 10x500mg | SLO | SK | | | | | 69195 | CIPROBID 250 | tbl obd 10x250mg | CAI | IND | | | | | 96039 | CIPRINOL 500 | tbl obd 10x500mg | KRK | SLO | | | | | 94453 | CIPRINOL 250 | tbl obd 10x250mg | KRK | SLO | | | | | 69196 | CIPROBID 500 | tbl obd 10x500mg | CAI | IND | | | | | 266.3 | J01MA03 | pefloxacin | p.o. | 0.8 | GM | 24,50 | | | 94156 | ABAKTAL | tbl obd 10x400mg | LEK | SLO | | | | | 266.4 | J01MA04 | enoxacin | p.o. | 0.8 | GM | 20,50 | | | | | | | | | | | | 266.5 | J01MA06 | norfloxacin | p.o. | 0.8 | GM | 20,50 | | | 44091 | GYRABLOCK 400 | tbl obd 1000x400mg | MOE | CY | | | | | 93465 | NOLICIN | tbl 20x400mg | KRK | SLO | | | | | 266.6 | J01MA07 | lomefloxacin | p.o. | 0.8 | GM | 24,50 | | | | | | | | | | | | 266.7 | J01MA08 | fleroxacin | p.o. | 0.4 | GM | 24,50 | | | | | | | | | | | | 266.8 | J01MA09 | sparfloxacin | p.o. | 0.2 | GM | 24,50 | P | | | | | | | | | | | 266.9 | J01MA12 | levofloxacin do 250 mg v jedné tabletě včetně | p.o. | 0,25 | GM | 75,00 | U/ATB | | | | | | | | | | | 266.10 | J01MA12 | levofloxacin nad 250 mg v jedné tabletě | p.o. | 0,25 | GM | 60,00 | U/ATB | | | | | | | | | | | 266.11 | J01MA | trovafloxacin | p.o. | 0,2 | GM | 24,50 | P | | | | | | | | | | | 266.12 | J01MB05 | kyselina oxolinová | p.o. | 1 | GM | 8,91 | | | 91101 | DESUROL | tbl 50x250mg | LEX | CZ | | | | | 267 | J01MA | fluorované chinolony | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 267.1 | J01MA01 | ofloxacin | parent. | 0.4 | GM | 212,23 | U/ATB | | 66137 | OFLOXIN INF | inf 1x100ml/200mg | LEX | CZ | | | | | 267.2 | J01MA02 | ciprofloxacin - infúze | parent. | 0.5 | GM | 212,23 | U/ATB | | 59829 | CIPRINOL 100MG/50ML | inf 1x50ml/100mg | KRK | SLO | | | | | 59830 | CIPRINOL 200MG/100ML | inf 1x100ml/200mg | KRK | SLO | | | | | 267.3 | J01MA02 | ciprofloxacin - injekce | parent. | 0.5 | GM | 190,00 | U/ATB | | | | | | | | | | | 267.4 | J01MA03 | pefloxacin | parent. | 0.8 | GM | 93,26 | U/ATB | | 94155 | ABAKTAL | inj 10x5ml/400mg | LEK | SLO | | | | | 267.5 | J01MA08 | fleroxacin | parent. | 0.4 | GM | 212,23 | U/ATB | | | | | | | | | | | 267.6 | J01MA12 | levofloxacin | parent | 0,25 | GM | 477,00 | U/ATB | | | | | | | | | | | 267.7 | J01MA | trovafloxacin | parent. | 0,2 | GM | 212,23 | U/ATB | | 268 | J01XA | ostatní antibiotika | parent. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 268.1 | J01XA01 | vankomycin | parent. | 2 | GM | 1265,30 | U/ATB | | 92290 | EDICIN 1GM | inj.sicc.1x1gm | LEK | SLO | | | | | 92289 | EDICIN 0.5GM | inj.sicc.1x500mg | LEK | SLO | | | | | 268.2 | J01XA02 | teikoplanin | parent. | 0.4 | GM | 2492,83 | U/ATB | | | | | | | | | | | 268.3 | J01XB01 | kolistin | parent. | 3 | MU | 109,34 | U/ATB | | 61178 | COLIMYCINE | inj sic 50x1mu | RBE | F | | | | | 268.4 | J01XB02 | polymyxin | parent. | 0.15 | GM | 103,09 | U/ATB | | | | | | | | | | | 268.5 | J01XX08 | linezolid | p.o. | 1,2 | GM | 4958,00 | U/ATB | | | | | | | | | | | 268.6 | J01XX08 | linezolid | parent | 1,2 | GM | 4958,00 | U/ATB | | 269 | J01XB | polymyxinová antibiotika | p.o. | U/ATB | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 269.1 | J01XB01 | kolistin | p.o. | 3 | MU | 42,82 | U/ATB | | 270 | J01XD | imidazolová chemoterapeutika | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 270.1 | J01XD01 | metronidazol | parent. | 1.5 | GM | 176,89 | U | | | | | | | | | | | 270.2 | J01XD03 | ornidazol | parent. | 1 | GM | 50,44 | U | | | | | | | | | | | 270.3 | J01XE01 | nitrofurantoin | p.o. | 0.2 | GM | 3,65 | | | 90510 | FURANTOIN LECIVA | tbl ent 20x100mg | LEX | CZ | | | | | 271 | J02AA | antimykotická antibiotika | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 271.1 | J02AA01 | amfotericin | parent. | 35 | MG | 279,36 | U | | 57548 | AMPHOTERICIN B SQUIBB | inj sic 1x50mg | BMJ | F | | | | | 271.2 | J02AA01 | amfotericin na tukových nosičích | parent. | 35 | MG | 1597,70 | U/ATB | | 272 | J02AB | imidazolová antimykotika | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 272.1 | J02AB02 | ketokonazol | p.o. | 0.2 | GM | 27,37 | | | 54516 | NIZORAL | tbl 30x200mg | JAG | I | | | | | 91739 | ORONAZOL | tbl 20x200mg | KRK | SLO | | | | | 31109 | NIZORAL | tbl 10x200mg | JAG | I | | | | | 273 | J02AB | imidazolová antimykotika | parent. | U | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 273.1 | J02AB01 | mikonazol | parent. | 1 | GM | 469,63 | U | | 274 | J02AC | triazolová antimykotika | p.o. | P | | | |
-
- Krátkodobou léčbu ordinuje gynekolog nebo dermatolog na základě kultivačního nebo mikroskopického vyšetření:
- a) vaginální mykózy nereagující na lokálně aplikovaná antimykotika
- b) recidivy vaginálních mykóz
-
- Vícedenní léčbu ordinuje infekcionista, hematolog, onkolog, specialista pracující na transplantačních jednotkách nebo dermatolog:
- a) systémové mykózy u imunokompromitovaných pacientů
- b) těžké formy slizničních a kožních mykóz vyvolaných kandidami nebo dermatofyty na základě kultivačního nebo mikroskopického vyšetření
- c) těžké formy nehtových mykóz (itrakonazol), platí-li alespoň jedna z následujících podmínek:
• postižení celé nehtové ploténky
• postižení minimálně čtyř nehtových plotének tak, že každá z nich má postižení zasahující více než 30% za volný okraj nehtu proximálním směrem
• postižení nehtu palce dolní končetiny
Podmínkou zahájení léčby ad c) je pozitivní mikroskopický nález a provedený odběr na mykologickou kultivaci.
- d) profylakticky u imunokompromitovaných pacientů nebo u pacientů před provedením transplantace
- e) itrakonazol tekuté lékové formy - léčba orální a oesophageální kandidózy a profylakticky u imunokompromitovaných pacientů
| 274.1 | J02AC01 | flukonazol ( pevné lékové formy 150 mg v 1 tabletě ) | p.o. | 0.15 | GM | 203,85 | P | | 10743 | MYCOSYST 150 MG | cps 4x150mg | GED | H | | | | | 53917 | FLUCONAZOL 150-SLOVAKOFARMA | cps 1x150mg | SLO | SK | | | | | 66039 | MYCOMAX 150 | cps 1x150mg | LEX | CZ | | | | | 59876 | MYCOSYST 150MG | cps 2x150mg | GED | H | | | | | 59875 | MYCOSYST 150MG | cps 1x150mg | GED | H | | | | | 59788 | DIFLAZON 150 | cps 1x150mg | KRK | SLO | | | | | 274.2 | J02AC01 | flukonazol - ostatní pevné lékové formy jiné než 150 mg v jedné tabletě | p.o. | 0.2 | GM | 262,18 | P | | 59786 | DIFLAZON 50 | cps 7x50mg | KRK | SLO | | | | | 59874 | MYCOSYST 100MG | cps 28x100mg | GED | H | | | | | 59873 | MYCOSYST 50MG | cps 7x50mg | GED | H | | | | | 59790 | DIFLAZON 200 | cps 20x200mg | KRK | SLO | | | | | 59789 | DIFLAZON 200 | cps 7x200mg | KRK | SLO | | | | | 59787 | DIFLAZON 100 | cps 28x100mg | KRK | SLO | | | | | 55396 | FLUCONAZOL 50-SLOVAKOFARMA | cps 7x50mg | SLO | SK | | | | | 66033 | MYCOMAX 50 | cps 28x50mg | LEX | CZ | | | | | 66036 | MYCOMAX 100 | cps 28x100mg | LEX | CZ | | | | | 55397 | FLUCONAZOL 50-SLOVAKOFARMA | cps 14x50mg | SLO | SK | | | | | 66037 | MYCOMAX 100 | cps 7x100mg | LEX | CZ | | | | | 66032 | MYCOMAX 50 | cps 7x50mg | LEX | CZ | | | | | 274.3 | J02AC01 | flukonazol (do 50 mg v 5 ml sirupu včetně) | p.o. | 0.2 GM | 479,01 | P | | | 66031 | MYCOMAX SIR | sir 1x100ml/500mg | LEX | CZ | | | | | 64950 | DIFLUCAN 50MG/5ML | plv pro sus 1x35ml | PFC | F | | | | | 274.4 | J02AC01 | flukonazol (nad 50 do 100mg v 5 ml sirupu včetně) | p.o. | 0.2 | GM | 436,59 | P | | | | | | | | | | | 274.5 | J02AC01 | flukonazol - tekuté lékové formy nad 100 mg v 5 ml sirupu | p.o. | 0.2 | GM | 349,25 | P | | | | | | | | | | | 274.6 | J02AC02 | itrakonazol (pevné lékové formy do 400 mg včetně v jednom baleni) | p.o. | 0.2 | GM | 95,60 | P | | | | | | | | | | | 274.7 | J02AC02 | itrakonazol (pevné lékové formy) nad 400 mg v jednom balení | p.o. | 0.2 | GM | 120,00 | P | | | | | | | | | | | 274.8 | J02AC02 | itrakonazol (tekuté lékové formy) | p.o. | 0.2 | GM | 391,27 | P | | 56067 | SPORANOX | sol 1x150ml/1.5gm | JAN | B | | | | | 274.9 | J02AX01 | flucytosin | p.o. | 10 | GM | 858,22 | P | | 275 | J02AC | triazolová antimykotika | parent. | U/P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Terapeuticky: těžké, život ohrožující systémové mykózy.
Profylakticky: u imunokomprimovaných pacientů nebo pacientů připravovaných k transplantaci.
| 275.1 | J02AC01 | flukonazol | parent. | 0.2 | GM | 550,00 | U/P | | 58431 | DIFLAZON | inf 1x100ml/200mg | KRK | SLO | | | | | 46979 | FLUCONAZOL-SLOVAKOFARMA PRO INF | inf 1x100ml/200mg | SLO | SK | | | | | 275.2 | J02AX01 | flucytosin | parent. | 10 | GM | 2710,83 | U/P | | | | | | | | | | | 275.3 | J02AX04 | caspofungin s obsahem 50 mg v jedné ampulce | parent. | 1 | DF | 17259,00 | U/ATB | | | | | | | | | | | 275.4 | J02AX04 | caspofungin s obsahem 70 mg v jedné ampulce | parent. | 1 | DF | 24163,00 | U/ATB | | 276 | J04AB | antibiotika k léčbě tuberkulózy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu rifabutinem ordinuje pneumolog nebo infekcionista: léčba tuberkulózy vyvolané atypickými mykobakteriemi.
| 276.1 | J04AB02 | rifampicin | p.o. | 0.6 | GM | 12,76 | | | 96780 | ARFICIN | cps 100x300mg | BLU | CHO | | | | | 276.2 | J04AB04 | rifabutin | p.o. | 0.15 | GM | 125,72 | P | | 277 | J04AB | antibiotika k léčbě tuberkulózy | parent. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 277.1 | J04AB03 | rifamycin | parent. | 0.6 | GM | 244,40 | | | 277.2 | J04AB30 | kapreomycin | parent. | 1 | GM | 553,11 | | | 278 | J04AC | hydrazidy k léčbě tuberkulózy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 278.1 | J04AC01 | isoniazid | p.o. | 0.3 | GM | 2,04 | | | 03303 | NIDRAZID | tbl 250x100mg | LEX | CZ | | | | | 279 | J04AK | další léčiva k léčbě tuberkulózy | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 279.1 | J04AK01 | pyrazinamid | p.o. | 1.5 | GM | 14,63 | | | 75508 | TISAMID | tbl 100x500mg | ORN | SF | | | | | 279.2 | J04AK02 | ethambutol | p.o. | 1.2 | GM | 12,22 | | | 03023 | SURAL | tbl 100x400mg | CHN | H | | | | | 280 | J04BA | chemoterapeutika k léčbě lepry | p.o. | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 280.1 | J04BA02 | dapson | p.o. | 50 | MG | 1,37 | | | 91888 | DISULONE 100 AU PROTOXAL.DE FER | tbl 100x100mg | LVN | F | | | | | 281 | J05A | antivirotika | p.o. | P | | | | | --- | --- | --- | --- | --- | --- | --- | --- |
Léčbu brivudinem, acyklovirem, famcyklovirem a valaciklovirem ordinuje infekcionista, onkolog, hematolog, gynekolog, dermatolog, klinický imunolog, neurolog a specialista pracující na transplantačních jednotkách:
- a) léčba iniciální fáze herpes genitalis u těhotných žen po 20. týdnu těhotenství,
- b) léčba herpes zoster a herpes genitalis u imunokomprimovaných pacientů (při cytostatické léčbě, léčbě imunosupresivy, léčbě kortikosteroidy, nebo u osob s prokázanou poruchou imunity, respektive u atopiků),
- c) léčba herpes zoster při lokalizaci v obličeji,
- d) profylaxe po alogenní transplantaci kostní dřeně.
Léčbu acyklovirem u pacientů s herpes zoster indikuje ošetřující lékař též odbornosti praktický lékař pro dospělé a praktický lékař pro děti a dorost.
Léčbu inosin pranobexem ordinuje alergolog nebo imunolog u pacientů s prokázanou poruchou imunity.
Léčbu antiretrovirovými léčivy (zidovudin, didanosin, zalcitabin, saquinavir, ritonavir, indavir, stavudin, efavirenz, nevirapin, nelfinavir, lamivudin a abacavir) indikuje infekcionista pracující v AIDS centrech.
Léčbu lamivudinem dále indikuje ošetřující lékař u chronické virové hepatitidy typu B.
Léčbu gancyklovirem ordinuje infekcionista, onkolog, hematolog a specialista pracující na transplantačních centrech:
- a) léčba a sekundární profylaxe závažných CMV infekcí u HIV/AIDS pacientů,
- b) profylaxe a léčba CMV infekcí u pacientů s allogenní a autologní transplantací kostní dřeně,
- c) profylaxe a léčba CMV infekcí u pacientů u orgánových transplantací.
Čtení tohoto dokumentu nenahrazuje čtení příslušného vydání Sbírky zákonů. Neneseme odpovědnost za případné nepřesnosti vyplývající z převodu originálu do tohoto formátu.
Tento text je zveřejněn za vlastních podmínek opětovného použití zdroje e-Sbírka, nikoli pod licencí Legalize ani pod licencí volného díla.
e-Sbírka
volné dílo (úřední díla podle § 3 písm. a) zákona č. 121/2000 Sb., autorského zákona)